These studies are old, but I am just posting them here as further support of the thyromimetic properties of androsterone. As we know, thyroid hormone is the primary regulator of levels of uric acid and serum lipids and Ray has recommended improvement of thyroid function as the primary method for improving gout and CVD.
EFFECT OF ATROMID ON PLASMA LIPIDS AND LIPROPROTEINS IN SUBJECTS WITH HYPERLIPOPROTEINEMIA. (A PRELIMINARY REPORT). - PubMed - NCBI
EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN N... - PubMed - NCBI
"ATROMID" IN ATHEROSCLEROSIS. - PubMed - NCBI
THE EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON THE EXCRETION OF URIC ACID. A PRELIMINARY REPORT. - PubMed - NCBI
Effect of atromid and its components on uric acid excretion and on gout. - PubMed - NCBI
Reduction of serum-lipid and uric-acid levels by an orally active androsterone. - PubMed - NCBI
THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID. - PubMed - NCBI
Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate. - PubMed - NCBI
EFFECT OF ATROMID ON PLASMA LIPIDS AND LIPROPROTEINS IN SUBJECTS WITH HYPERLIPOPROTEINEMIA. (A PRELIMINARY REPORT). - PubMed - NCBI
EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN N... - PubMed - NCBI
"ATROMID" IN ATHEROSCLEROSIS. - PubMed - NCBI
THE EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON THE EXCRETION OF URIC ACID. A PRELIMINARY REPORT. - PubMed - NCBI
Effect of atromid and its components on uric acid excretion and on gout. - PubMed - NCBI
Reduction of serum-lipid and uric-acid levels by an orally active androsterone. - PubMed - NCBI
THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID. - PubMed - NCBI
Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate. - PubMed - NCBI